2013-2017: PhD from Department of Materials and Environmental Chemistry, Stockholm University, Sweden. Title ʺLanthanide Metal-Organic Frameworks and Hierarchical Porous Zeolitic Imidazolate Frameworks: Synthesis, Properties, and Applicationsʺ
2011-2013: M.Sc in Nanobiomedicine, National Sun-Yat Sen University, China (ROC)
2009-2010: Pre-Master–Physical Organic Chemistry-Assuit University, Egypt, Grade: 3.4 (87.71%).
2003-2007: B.Sc Chemistry Department–Assuit University- Egypt, Grade: 3.32 (84.059%)
Research Experience & interest
The research interest of Hani Abdelhamid is focused broadly on science and technology at the nanoscale and for material science to push scientific boundaries in diverse areas of biochemistry, biology, biomedicine biotechnology, nanocatalysis and laser based analytical. The main thrusts are concentrated on the topics as below:
1) Nanotechnology: synthesis, characterization, and applications.
2) Material Chemistry, synthesis, characterization, and applications.
3) Metal-Organic Frameworks (MOFs), synthesis, characterization, and applications.
4) Inorganic and structural chemistry.
5) Analytical Chemistry.
6) Solar cells and Nanocatalysis.
7) Nano-Biomedicine and Nano-Biotechnology.
8) Biochemistry and Biochemical research methods.
9) Metallodrug-protein interactions using Nanomaterials based- laser analytical tools.
10) Biosensor based on nanomaterials for pathogenic bacteria and biomolecules.
Research fields include translational research, invasion, metastasis, disseminated tumor cells, transcription, tumor-associated proteolysis, targeted therapy, micro-RNA, molecular staging of cancer. Associate Editor of the International Journal of Cancer, and on the Editorial Boards of: Advances in Medical Sciences, Journal of Cellular and Molecular Medicine, Frontiers in Molecular and Cellular Oncology, The Open Surgical Oncology Journal.
Dr Andersson is an Assistant Professor in Experimental Neurology at Lund University and group leader of Cellular Neurophysiology and Epilepsy group. Her research focuses on underlying mechanisms of and new treatments for epilepsy in the developing brain. This is done using different methods, the main one being electrophysiology, in vivo and in vitro.
Training: Dentistry, Biomedical Research, Bioengineering, Pathology
Postdoctoral: TGF-beta, wound healing, regeneration, radiation biology, light biology, stem cells, biomaterial, Lasers.
Current: Clinical translational research and molecular mechanism.
Positions: Past-President, NAALT; President-Elect WALT, Co-Chair SPIE, Chair, ASLMS
Interests: Signal Transduction, Lasers, Biological regulation, Photobiomodulation.
Director of the Cambridge Centre for Neuropsychiatric Research at Cambridge University. Practising clinician (with an Honorary Consultant position in General Adult Psychiatry at Addenbrookes Hospital, Cambridge). Co-founder of Psynova Neurotech Ltd. Professor for Tranlational Neuroscience at Erasmus University Medical Centre, Department of Neuroscience, Rotterdam.
--- CURRENT POSITION ---
CEO of neurochlore and B ATherapeutics
--- EDUCATION ---
° 1973-1979 - Post-doctoral & sabbatical studies: University of Cambridge (UK), University of Oslo (Norway) and McGill University (Canada)
° 1971 - Doctorat ès-sciences, Université de Paris VI (France)
° 1966 - B Sc. Biochemistry-Physiology, Hebrew University of Jerusalem (Israel)
--- AWARDS ---
° 2014 - Finalist Créa13 -Neurochlore
° 2013 - Award « Tremplins de La Provence » - Neurochlore
° 2012 - Award of the of the FNRS ( Fonds de la Recherche Scientifique de Belgique) of Belgium
° 2010 - Award of the European Society of Epilepsy
° 2009 - Award of the Grand Prix de la Recherche médicale de l'INSERM
° 2009 - Docteur Honoris causae, Liège University (Belgium)
° 2006 - Rotary Brain Research Award
° 2002 - The Health Price (Grand Prix de la Santé) of the Foundation of French Electricity ° 2000 - The American Epilepsy Society Research Award for outstanding research in epilepsies
Professor, Director of the Division of Biostatistics & Medical Informatics, Department of Epidemiology and Public Health, University of Maryland - Baltimore. Adjunct professor University of Copenhagen, Denmark. 20+ awards and honors incl. ESTRO Gold Medal, MD Anderson Distinguished Alumnus Award, Honorary Life member Assoc. of Radiation Oncologists of India & Belgian Soc. for Therapeutic Radiology and Oncology. 370+ publications, H-index 62 Web of Science.
Dr. Berghout received her PhD in Biochemistry from McGill University in Montreal, QC where she researched the genetics of complex traits and susceptibility to infectious disease in humans and mouse models. Following that, she spent three years as the Outreach Coordinator for the Mouse Genome Informatics (MGI) database in Bar Harbor, ME. There, she trained researchers in genetics, genomics, data structures and data mining to answer biological questions, and worked closely with other members of the MGI group to develop and optimize the MGI resource. Now her research interests include genetics of all kinds, personalized medicine, big data, and scientific communication. She is currently pursuing projects in precision medicine for analysis of transcriptome data from patients with rare lung diseases (Sarcoidosis, Coccidiomycosis), and integrative network analysis of complex traits including Alzheimer's Disease. She is currently appointed at the University of Arizona's Center for Biomedical Informatics and Biostatistics (CB2) and The Center for Genetics and Genomic Medicine (TCG2M) in Tucson, AZ.
I am a movement disorders neuropsychiatrist. My research is primarily focused on neuroimaging and dopamine, especially in people with Tourette syndrome and Parkinson disease. I have also developed methods for structural imaging volumetry, analysis of brain images in nonhuman species, pharmacological fMRI (phMRI), and statistical analysis of anatomy-function relationships in deep brain stimulation (DBS).
A.W. and Mary Margaret Clausen Distinguished Professor and Director, Hormone Research Institute. Serves on the Science Translational Medicine advisory board and founding Director, Immune Tolerance Network. A recipient of a Guggenheim Fellowship and elected member of the Academy of Arts and Sciences and National Academy of Medicine. Dr. Bluestone has spent over 35 years working as an immunologist interested in immune tolerance as it relates to autoimmunity and organ transplantation.
Prof. George P Chrousos is internationally recognized for his research on the glucocorticoid signaling system of the cell, on the diseases of the hypothalamic-pituitary-adrenal axis, and on the physiological and molecular mechanisms of stress. He is one of the 250 most cited scientists internationally (ISI highly cited) included not only in the list of Clinical Medicine, but also in that of Biology and Biochemistry, and the highest cited clinical endocrinologist and pediatrician in the world.
Professor of Pathology and Immunology at the University of Verona, Italy. Dr. Constantin has long-standing expertise in vascular inflammation and leukocyte trafficking with particular focus on the central nervous system. She has a M.D. degree and Residency in Neurology from the University of Milan, and Ph.D. degree from the University of Verona. For her neuroimmunology studies she received several national and international awards. She was elected in the AcademiaNet for excellent woman academics.